REGENXBIO Inc. (RGNX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in Capital, Common StockUSD $1.27B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-875.00K; Retained Earnings (Accumulated Deficit)USD $-1.19B.
- 2026-03-31: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in Capital, Common StockUSD $1.24B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-870.00K; Retained Earnings (Accumulated Deficit)USD $-1.22B.
- 2025-12-31: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in Capital, Common StockUSD $1.23B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-687.00K; Retained Earnings (Accumulated Deficit)USD $-1.13B.
- 2025-09-30: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in Capital, Common StockUSD $1.22B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-652.00K; Retained Earnings (Accumulated Deficit)USD $-1.06B.
REGENXBIO Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00K | $1.27B | $-875.00K | $-1.19B | $71.77M | 3 month · $9.05M 6 month · $17.67M | (m) |
| 2026-03-31 | $5.00K | $1.24B | $-870.00K | $-1.22B | $21.08M | 3 month · $8.62M | (m) |
| 2025-12-31 | $5.00K | $1.23B | $-687.00K | $-1.13B | $102.73M | 12 month · $34.56M | 12 month · $1.61M |
| 2025-09-30 | $5.00K | $1.22B | $-652.00K | $-1.06B | $161.45M | 3 month · $9.00M 9 month · $26.19M | 9 month · $1.61M |
| 2025-06-30 | $5.00K | $1.21B | $-750.00K | $-996.94M | $213.68M | 3 month · $8.65M 6 month · $17.19M | 3 month · $1.61M 6 month · $1.61M |
| 2025-03-31 | $5.00K | $1.20B | $-762.00K | $-926.07M | $274.20M | 3 month · $8.54M | (m) |
| 2024-12-31 | $5.00K | $1.19B | $-741.00K | $-932.15M | $259.65M | 12 month · $38.46M | (m) |
| 2024-09-30 | $5.00K | $1.18B | $-582.00K | $-880.96M | $301.42M | 3 month · $9.88M 9 month · $28.92M | (m) |
| 2024-06-30 | $5.00K | $1.17B | $-2.27M | $-821.37M | $348.27M | 3 month · $9.44M 6 month · $19.04M | (m) |
| 2024-03-31 | $5.00K | $1.16B | $-3.23M | $-768.38M | $390.67M | 3 month · $9.60M | (m) |
| 2023-12-31 | $4.00K | $1.02B | $-4.43M | $-705.05M | $311.74M | 12 month · $40.27M | (m) |
| 2023-09-30 | $4.00K | $1.01B | $-7.41M | $-642.16M | $363.10M | 3 month · $10.22M 9 month · $31.93M | (m) |
| 2023-06-30 | $4.00K | $996.24M | $-10.10M | $-580.29M | $405.86M | 3 month · $10.50M 6 month · $21.71M | (m) |
| 2023-03-31 | $4.00K | $984.99M | $-11.62M | $-508.23M | $465.14M | 3 month · $11.21M | (m) |
| 2022-12-31 | $4.00K | $973.14M | $-15.40M | $-441.55M | $516.20M | 12 month · $40.79M | (m) |
| 2022-09-30 | $4.00K | $963.69M | $-18.26M | $-381.62M | $563.82M | 3 month · $10.24M 9 month · $31.38M | (m) |
| 2022-06-30 | $4.00K | $951.41M | $-14.76M | $-306.13M | $630.52M | 3 month · $10.34M 6 month · $21.14M | (m) |
| 2022-03-31 | $4.00K | $939.57M | $-11.95M | $-237.96M | $689.67M | 3 month · $10.80M | (m) |
| 2021-12-31 | $4.00K | $928.10M | $-2.57M | $-161.23M | $764.30M | 12 month · $38.81M | (m) |
| 2021-09-30 | $4.00K | $917.95M | $-1.28M | $-455.25M | $461.41M | 3 month · $9.73M 9 month · $29.65M | (m) |
| 2021-06-30 | $4.00K | $905.35M | $-1.25M | $-396.85M | $507.25M | 3 month · $9.99M 6 month · $19.91M | (m) |
| 2021-03-31 | $4.00K | $895.08M | $-1.37M | $-339.21M | $554.50M | 3 month · $9.92M | (m) |
| 2020-12-31 | $4.00K | $667.18M | $-360.00K | $-289.07M | $377.75M | 12 month · $31.95M | (m) |
| 2020-09-30 | $4.00K | $658.22M | $263.00K | $-242.83M | $415.66M | 3 month · $8.04M 9 month · $24.37M | (m) |
| 2020-06-30 | $4.00K | $648.73M | $750.00K | $-251.62M | $397.86M | 3 month · $8.32M 6 month · $16.33M | (m) |
| 2020-03-31 | $4.00K | $638.59M | $-580.00K | $-217.86M | $420.15M | 3 month · $8.02M | (m) |
| 2019-12-31 | $4.00K | $627.81M | $205.00K | $-177.82M | $450.20M | 12 month · $26.85M | (m) |
| 2019-09-30 | $4.00K | $619.39M | $363.00K | $-151.36M | $468.39M | 3 month · $7.16M 9 month · $19.98M | (m) |
| 2019-06-30 | $4.00K | $610.89M | $471.00K | $-116.77M | $494.59M | 3 month · $7.10M 6 month · $12.82M | (m) |
| 2019-03-31 | $4.00K | $602.42M | $-59.00K | $-115.32M | $487.05M | 3 month · $5.72M | (m) |
| 2018-12-31 | $4.00K | $592.58M | $-720.00K | $-83.02M | $508.85M | 12 month · $16.64M | (m) |
| 2018-09-30 | $4.00K | $582.25M | $-874.00K | $-87.32M | $494.06M | 3 month · $4.48M 9 month · $11.76M | (m) |
| 2018-06-30 | $3.00K | $386.11M | $-771.00K | $-68.12M | $317.22M | 3 month · $3.98M 6 month · $7.27M | (m) |
| 2018-03-31 | $3.00K | $378.95M | $-903.00K | $-78.71M | $299.34M | 3 month · $3.29M | (m) |
| 2017-12-31 | $3.00K | $371.50M | $-715.00K | $-187.76M | $183.03M | 12 month · $10.61M | (m) |
| 2017-09-30 | $3.00K | $366.96M | $-553.00K | $-171.76M | $194.65M | (m) | (m) |
| 2017-06-30 | $3.00K | $363.39M | $-646.00K | $-151.05M | $211.70M | (m) | (m) |
| 2017-03-31 | $3.00K | $350.05M | $-572.00K | $-136.58M | $212.90M | (m) | (m) |
| 2016-12-31 | $3.00K | $276.35M | $-33.00K | $-114.59M | $161.74M | 12 month · $7.03M | (m) |
| 2016-09-30 | $3.00K | $274.35M | $853.00K | $-94.98M | $180.23M | (m) | (m) |
| 2016-06-30 | $3.00K | $272.48M | $521.00K | $-76.83M | $196.18M | (m) | (m) |
| 2016-03-31 | $3.00K | $270.71M | $275.00K | $-62.39M | $208.60M | (m) | (m) |
| 2015-12-31 | $3.00K | $269.14M | $-719.00K | $-51.62M | $216.81M | 12 month · $2.92M | (m) |
| 2015-09-30 | $3.00K | $268.27M | $-26.00K | $-46.44M | $221.81M | (m) | (m) |
| 2014-12-31 | (m) | $10.52M | (m) | $-28.81M | $-18.29M | 12 month · $319.00K | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | $-13.92M | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | $-8.11M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |